Company news
Pharmalundensis Ab (NGM:PHAL) news
Pharmalundensis Ab news releases on 6ix. Latest, May 28, 2026: PHAL: Net loss widened to -1.56 million SEK; delisting and international financing initiatives…
Press releases & updates
PHAL: Net loss widened to -1.56 million SEK; delisting and international financing initiatives underway
May 28, 2026
PHAL: Net loss deepened in 2025 as focus shifts to international funding and clinical trial execution
February 5, 2026
PHAL: Net loss increased, but strong market interest in Minievaporator offers future upside
November 20, 2025
PHAL: Losses increased as net sales stayed at zero; new capital extends operations but debt remains
August 21, 2025
PHAL: Net loss persists, but R&D and cleantech advances drive optimism amid tight liquidity
May 15, 2025
PHAL: Net loss narrowed, Phal-501 advanced, and major rights issue to fund clinical trials in 2025
February 12, 2025
PHAL: Phal-501 shows promise for heavy metal detox; funding secured, but more needed by 2025
November 21, 2024
PHAL: Phal-501 clinical prep and rights issue mark key steps as losses narrow and CleanTech gains traction
August 15, 2024